Frontlight ResearchEarly access
CompletedNo phase
NEUROvascular NAVigation With Remotely Controlled Deflectable Guidewire, Study II (NeuroNAV Study II)
Key facts
- Who runs it
- Artiria Medical
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 28 people enrolled
- Started
- 18 Jun 2025
- Ended
- 12 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- SmartGUIDE (deflectable guidewire)
- Any standard of care guidewire
- Record updated
- 24 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- >18 years of age
- Informed consent signed by the patient
- Confirmed cerebral unruptured aneurysm treatable via transcatheter approach
Who cannot take part
- Known prior vascular stenosis or dissection or injury to vessels intended to be catheterized during study procedures
- Known contraindication to intravascular contrast material that cannot be adequately controlled with pre-medication
- Subjects currently enrolled in another investigational device or drug study that clinically interferes with the current study endpoints
- Known disorder of vascular fragility with propensity to vascular injury (e.g., Ehlers-Danlos syndrome)
- Acute phase myocardial infarction or uncontrolled cardiac arrhythmia
- Bleeding disorder which limits the use of antiplatelet and/or anticoagulant therapy
- Known hypersensitivity to Nickel
- Uncontrolled serum electrolyte imbalance
- Pregnancy or lactation
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of the study is to confirm the safe and successful use of the SmartGUIDE guidewire, when used in neuro interventions. The performance of the SmartGUIDE guidewire in terms of safe and successful navigation within the neurovasculature will be compared to standard of care guidewire on the market.
The 2 groups in the trial
- SmartGUIDE (deflectable guidewire)Treatment being tested
- Any standard of care guidewireExisting treatment, for comparison
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 24 August 2026